We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


WHO Changes SARS-CoV-2 Virus Test Criteria to Reduce False Positives

In its updated guidance, the World Health Organization (WHO; Geneva, Switzerland) has cautioned experts not to rely solely on the results of a PCR test to detect the SARS-CoV-2 virus and consider the results in combination with other factors such as timing of sampling, specimen type, and assay specifics, among others. More...
25 Jan 2021
Image: Rhinostics Standard Nasal Swab (Photo courtesy of Business Wire)

Procter & Gamble’s Novel Fully Injection-Molded Polypropylene Nasal Swab Improves Speed of COVID-19 Testing

A novel polypropylene nasal swab developed for COVID-19 testing that allows for easy collection from the front of the nose and provides sample concentration of up to 30 fold over other swabs in viral transport media is likely to positively impact testing availability. More...
25 Jan 2021
Image: Contact tracing app (Photo courtesy of Canva)

Daily Rapid Lateral Flow COVID-19 Tests for Traced Contacts for Five Days Could Replace Requirement to Quarantine, Reveals Study

Additional testing with either a PCR or lateral flow antigen (LFA) test could potentially reduce the quarantine time of contacts of a confirmed case to seven days from the WHO recommended 14-day quarantine period without raising the risk of onward transmission, according to a new modeling study. More...
25 Jan 2021
Image: New AI-Driven COVID-19 Testing Algorithm Could Lead to Fewer Infections (Photo courtesy of Giovanni Cancemi)

New AI-Driven COVID-19 Testing Algorithm Could Lead to Fewer Infections

A new artificial intelligence (AI) algorithm could help leaders of governments and organizations make better informed decisions on how many symptomatic and asymptomatic individuals to test for COVID-19 with a limited supply of daily tests, and at what stage of the pandemic. More...
25 Jan 2021
Image: Innovative pain-free microneedle patch with unprecedented sensitivity (Photo courtesy of Washington University in St. Louis)

Innovative Pain-Free Microneedle Patch with Unprecedented Sensitivity Can Test for Level of Antibodies Against COVID-19

A nearly pain-free microneedle patch developed by researchers can be applied to the skin, capture a biomarker of interest and, thanks to its unprecedented sensitivity, allow clinicians to detect the presence of antibodies that signal a viral or bacterial infection, such as SARS-CoV-2. More...
25 Jan 2021

COVID-19 Testing Demand to Help In-Vitro Diagnostics (IVD) Market Reach USD 118.5 Billion by 2027

 The global in-vitro diagnostics (IVD) market is projected to register a CAGR of 7% from 2020 to 2027 to reach USD 118.5 billion by 2027, driven mainly by the increased demand for diagnostic testing for understanding and managing infectious diseases, such as COVID-19. More...
22 Jan 2021
Image: ErbaMDx SARS-CoV-2 RT-PCR Kit (Photo courtesy of Erba Mannheim)

Erba Mannheim Launches Second Generation SARS-CoV-2 RT-PCR Assay with Room Temperature Storage

Erba Mannheim (London, UK) has launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for the detection of SARS-CoV-2. More...
22 Jan 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.